{"id":"https://openalex.org/W2080172914","doi":"https://doi.org/10.1097/00004714-199806000-00002","title":"Clinical Characteristics of Response to Fluoxetine Treatment of Obsessive-Compulsive Disorder","display_name":"Clinical Characteristics of Response to Fluoxetine Treatment of Obsessive-Compulsive Disorder","publication_year":1998,"publication_date":"1998-06-01","ids":{"openalex":"https://openalex.org/W2080172914","doi":"https://doi.org/10.1097/00004714-199806000-00002","mag":"2080172914","pmid":"https://pubmed.ncbi.nlm.nih.gov/9617976"},"language":"en","primary_location":{"id":"doi:10.1097/00004714-199806000-00002","doi":"https://doi.org/10.1097/00004714-199806000-00002","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004714-199806000-00002","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113714913","display_name":"Deborah L. Ackerman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Deborah L. Ackerman","raw_affiliation_strings":["Department of Epidemiology, UCLA School of Public Health, Los Angeles, California 90095, USA","(Ackerman) Department of Epidemiology, UCLA School of Public Health, Los Angeles, California","(Bystritsky) Anxiety Disorders Clinic, UCLA Neuropsychiatric Institute, Los Angeles, California","Address requests for reprints to: Deborah L. Ackerman, PhD, UCLA School of Public Health, Box 951772, Los Angeles CA 90095","Received May 2, 1997","accepted after revision November 12, 1997"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Epidemiology, UCLA School of Public Health, Los Angeles, California 90095, USA","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"(Ackerman) Department of Epidemiology, UCLA School of Public Health, Los Angeles, California","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"(Bystritsky) Anxiety Disorders Clinic, UCLA Neuropsychiatric Institute, Los Angeles, California","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"Address requests for reprints to: Deborah L. Ackerman, PhD, UCLA School of Public Health, Box 951772, Los Angeles CA 90095","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"Received May 2, 1997","institution_ids":[]},{"raw_affiliation_string":"accepted after revision November 12, 1997","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005273634","display_name":"Sander Greenland","orcid":"https://orcid.org/0000-0003-4364-3279","observed_orcids":["https://orcid.org/0000-0003-4364-3279"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sander Greenland","raw_affiliation_strings":["(Ackerman) Department of Epidemiology, UCLA School of Public Health, Los Angeles, California","(Bystritsky) Anxiety Disorders Clinic, UCLA Neuropsychiatric Institute, Los Angeles, California","Address requests for reprints to: Deborah L. Ackerman, PhD, UCLA School of Public Health, Box 951772, Los Angeles CA 90095","Received May 2, 1997","accepted after revision November 12, 1997"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"(Ackerman) Department of Epidemiology, UCLA School of Public Health, Los Angeles, California","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"(Bystritsky) Anxiety Disorders Clinic, UCLA Neuropsychiatric Institute, Los Angeles, California","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"Address requests for reprints to: Deborah L. Ackerman, PhD, UCLA School of Public Health, Box 951772, Los Angeles CA 90095","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"Received May 2, 1997","institution_ids":[]},{"raw_affiliation_string":"accepted after revision November 12, 1997","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090320461","display_name":"Alexander Bystritsky","orcid":"https://orcid.org/0000-0003-2869-9370","observed_orcids":["https://orcid.org/0000-0003-2869-9370"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexander Bystritsky","raw_affiliation_strings":["(Ackerman) Department of Epidemiology, UCLA School of Public Health, Los Angeles, California","(Bystritsky) Anxiety Disorders Clinic, UCLA Neuropsychiatric Institute, Los Angeles, California","Address requests for reprints to: Deborah L. Ackerman, PhD, UCLA School of Public Health, Box 951772, Los Angeles CA 90095","Received May 2, 1997","accepted after revision November 12, 1997"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"(Ackerman) Department of Epidemiology, UCLA School of Public Health, Los Angeles, California","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"(Bystritsky) Anxiety Disorders Clinic, UCLA Neuropsychiatric Institute, Los Angeles, California","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"Address requests for reprints to: Deborah L. Ackerman, PhD, UCLA School of Public Health, Box 951772, Los Angeles CA 90095","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"Received May 2, 1997","institution_ids":[]},{"raw_affiliation_string":"accepted after revision November 12, 1997","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I161318765"],"apc_list":null,"apc_paid":null,"fwci":2.488,"has_fulltext":false,"cited_by_count":65,"citation_normalized_percentile":{"value":0.88739003,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"18","issue":"3","first_page":"185","last_page":"192"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11123","display_name":"Obsessive-Compulsive Spectrum Disorders","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11123","display_name":"Obsessive-Compulsive Spectrum Disorders","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11132","display_name":"Psychoanalysis and Psychopathology Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fluoxetine","display_name":"fluoxetine","score":0.8489999771118164},{"id":"https://openalex.org/keywords/obsessive-compulsive-disorder","display_name":"obsessive-compulsive disorder","score":0.9950000047683716},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.8259999752044678},{"id":"https://openalex.org/keywords/predictors-of-treatment-response","display_name":"predictors of treatment response","score":0.8370000123977661},{"id":"https://openalex.org/keywords/symptom-severity","display_name":"symptom severity","score":0.5640000104904175},{"id":"https://openalex.org/keywords/obsession","display_name":"obsession","score":0.8180000185966492},{"id":"https://openalex.org/keywords/compulsions","display_name":"compulsive behavior","score":0.9900000095367432},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.7770000100135803},{"id":"https://openalex.org/keywords/prior-treatment-history","display_name":"prior treatment history","score":0.5849999785423279},{"id":"https://openalex.org/keywords/remission","display_name":"remission","score":0.5950000286102295},{"id":"https://openalex.org/keywords/age-of-onset","display_name":"age of onset","score":0.6589999794960022},{"id":"https://openalex.org/keywords/antidepressant-dosage","display_name":"antidepressant dosage","score":0.49399998784065247},{"id":"https://openalex.org/keywords/placebo-response","display_name":"placebo response","score":0.40299999713897705}],"concepts":[{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.8389692306518555},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6935856342315674},{"id":"https://openalex.org/C2777669559","wikidata":"https://www.wikidata.org/wiki/Q407617","display_name":"Sertraline","level":4,"score":0.6288560032844543},{"id":"https://openalex.org/C2776466505","wikidata":"https://www.wikidata.org/wiki/Q385555","display_name":"Hamilton Rating Scale for Depression","level":4,"score":0.6262891292572021},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.5735109448432922},{"id":"https://openalex.org/C83849319","wikidata":"https://www.wikidata.org/wiki/Q7295720","display_name":"Rating scale","level":2,"score":0.5189392566680908},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4976785480976105},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4828501343727112},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4644738435745239},{"id":"https://openalex.org/C139265228","wikidata":"https://www.wikidata.org/wiki/Q5283089","display_name":"Distress","level":2,"score":0.4461570084095001},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.42997390031814575},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.41679826378822327},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4142269492149353},{"id":"https://openalex.org/C70410870","wikidata":"https://www.wikidata.org/wiki/Q199906","display_name":"Clinical psychology","level":1,"score":0.36719828844070435},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.19954293966293335},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.12764710187911987},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.12487465143203735},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.08035850524902344},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C138496976","wikidata":"https://www.wikidata.org/wiki/Q175002","display_name":"Developmental psychology","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005473","descriptor_name":"Fluoxetine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009771","descriptor_name":"Obsessive-Compulsive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018687","descriptor_name":"Antidepressive Agents, Second-Generation","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/00004714-199806000-00002","doi":"https://doi.org/10.1097/00004714-199806000-00002","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004714-199806000-00002","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:9617976","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9617976","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical psychopharmacology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8399999737739563}],"study_designs":[],"awards":[{"id":"https://openalex.org/G555552293","display_name":"PREDICTORS OF RESPONSE TO SSRIS IN OCD","funder_award_id":"1r03mh053873-01","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G8056245242","display_name":null,"funder_award_id":"MH-53873","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337346","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W9810277","https://openalex.org/W64975721","https://openalex.org/W114719203","https://openalex.org/W170843568","https://openalex.org/W1679486966","https://openalex.org/W1681871297","https://openalex.org/W1971193690","https://openalex.org/W1971573210","https://openalex.org/W1972997870","https://openalex.org/W1980290422","https://openalex.org/W1980532101","https://openalex.org/W1983110671","https://openalex.org/W1990454293","https://openalex.org/W1994627351","https://openalex.org/W2001138924","https://openalex.org/W2050252906","https://openalex.org/W2062931826","https://openalex.org/W2067830359","https://openalex.org/W2068293443","https://openalex.org/W2078989227","https://openalex.org/W2086894297","https://openalex.org/W2088906118","https://openalex.org/W2097231409","https://openalex.org/W2112258504","https://openalex.org/W2141768440","https://openalex.org/W2271776958","https://openalex.org/W2395248606","https://openalex.org/W2461031909","https://openalex.org/W4285139808","https://openalex.org/W4299396253","https://openalex.org/W4321428229"],"related_works":["https://openalex.org/W2412595961","https://openalex.org/W2086045023","https://openalex.org/W2044098244","https://openalex.org/W2466513681","https://openalex.org/W2063768158","https://openalex.org/W2400010629","https://openalex.org/W2050252906","https://openalex.org/W170843568","https://openalex.org/W2013947651","https://openalex.org/W2091595086"],"abstract_inverted_index":{"Fluoxetine":[0,81],"is":[1],"effective":[2,84],"in":[3,100,110,200],"treating":[4],"obsessive-compulsive":[5],"disorder":[6],"(OCD).":[7],"Nonetheless,":[8],"a":[9,25,97,107,114,127],"substantial":[10],"number":[11],"of":[12,30,37,57,60,66,71,129,179,186],"patients":[13,125],"do":[14],"not":[15,169],"respond":[16],"or":[17,136,154,158,189],"have":[18],"only":[19,138],"partial":[20],"improvement.":[21],"Data":[22],"generated":[23],"by":[24],"multicenter,":[26],"placebo-controlled,":[27],"fixed-dose":[28],"trial":[29],"fluoxetine":[31],"were":[32,42,122],"reanalyzed":[33],"to":[34,44,195,198],"identify":[35],"characteristics":[36],"responders.":[38],"Multiple":[39],"regression":[40],"methods":[41],"used":[43],"evaluate":[45],"the":[46,187,201],"relationship":[47],"between":[48,173],"therapeutic":[49],"response":[50,174],"and":[51,73,79,106,119,150,175,183],"baseline":[52],"measures":[53],"such":[54],"as":[55],"severity":[56],"symptoms,":[58],"type":[59],"symptoms":[61],"(obsessions,":[62],"compulsions,":[63],"depression),":[64],"course":[65],"illness,":[67],"previous":[68,133],"treatment,":[69],"age":[70,178],"onset,":[72,181],"other":[74],"demographic":[75,188],"factors":[76,191],"(age,":[77],"race,":[78],"sex).":[80],"was":[82,94,193],"more":[83,143],"than":[85,113],"placebo":[86,202],"on":[87],"all":[88],"outcome":[89],"measures.":[90],"A":[91],"60-mg":[92],"dosage":[93],"associated":[95],"with":[96,126,131,137,142,147,155],"greater":[98,108,148],"drop":[99,109],"Yale-Brown":[101],"Obsessive-Compulsive":[102],"Scale":[103,162],"total":[104],"score":[105],"Compulsion":[111],"items":[112],"20-mg":[115],"dosage.":[116],"Response":[117],"rates":[118],"overall":[120],"improvement":[121,199],"greatest":[123],"for":[124,163],"history":[128],"remissions,":[130],"no":[132],"drug":[134],"treatment":[135],"prior":[139],"behavior":[140],"therapy,":[141],"severe":[144],"OCD":[145,180],"(especially":[146],"interference":[149],"distress":[151],"from":[152],"obsessions),":[153],"either":[156],"low":[157],"high":[159],"Hamilton":[160],"Rating":[161],"Depression":[164],"scores.":[165],"This":[166],"study":[167],"did":[168],"detect":[170],"any":[171],"associations":[172],"current":[176],"age,":[177],"gender,":[182],"race.":[184],"None":[185],"clinical":[190],"evaluated":[192],"found":[194],"be":[196],"related":[197],"group.":[203]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":5}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}